(19)
(11) EP 3 380 082 A2

(12)

(88) Date of publication A3:
03.08.2017

(43) Date of publication:
03.10.2018 Bulletin 2018/40

(21) Application number: 16816494.5

(22) Date of filing: 23.11.2016
(51) International Patent Classification (IPC): 
A61K 9/127(2006.01)
A61K 31/70(2006.01)
A61K 31/704(2006.01)
A61K 31/505(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/US2016/063668
(87) International publication number:
WO 2017/091767 (01.06.2017 Gazette 2017/22)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 25.11.2015 US 201562259757 P
14.09.2016 US 201662394567 P

(71) Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Oakland, CA 94607-5200 (US)

(72) Inventors:
  • MITRAGOTRI, Samir
    Santa Barbara, CA 93111 (US)
  • BROTO, Marta
    Santa Barbara, CA 93106-2055 (US)
  • CAMACHO, Kathryn, M.
    Santa Barbara, CA 93103 (US)
  • MENEGATTI, Stefano
    Raleigh, NC 27606 (US)

(74) Representative: Hutter, Anton et al
Venner Shipley LLP 200 Aldersgate
London EC1A 4HD
London EC1A 4HD (GB)

   


(54) DRUG FORMULATIONS FOR CANCER TREATMENT